Boston, MA 07/26/2013 (wallstreetpr) – Organovo holdings Inc (NASDAQ:ONVO) has moved drastically this month showing a lot of movement on the charts. The stock on July 8, 2013 was at a price of $3.90. Since then the stock has shown a constant upward movement reaching $6.30 as on closing of July 25, 2013, gaining almost 63% on the charts. The stock also reached a peak of 52 week price of $8.5 during this period. This mobility was also reflected in the volumes traded. The volumes which were traded during the above period averaged at 5000K, touching 8166K on July 17, 2013. These numbers reverts the high advancement in the stock where it has a 90 day average volume trading at 1027K.
The market is keeping a bullish view on the stock which recent advancements. Analysts are suggesting a strong hold recommendation for the stock. The developments have taken the market capitalization of the company to 392.112M as on the closing of July 25, 2013 with 62.24M shares.
The movements have been credited to the up listing of the shares recently on New York Stock Exchange (NYSE). The listing will further grant much needed liquidity to the company as it will receive more institutional funds. Being listed on reputed stock exchange will increase the credibility to the company giving a firm cushion to the history of good performance of the stock.
Organovo is a research company engaged in using Three Dimensional printing and bio technology. The technology is used to develop drugs to cure damaged human tissue and organs. The company has a market monopoly in Bio printing with its product NovoGen MMX.
The company also announced on July 24, 2013 of its collaboration with Methuselah Foundation for granting research fund to institutions engaged in advanced bio medical research to drive the medical research technology forward.
